GLPwatch
Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
NCT02016846 · Unknown status
Last updated 2026-05-28This clinical trial tests whether the medication liraglutide can help manage high blood sugar caused by glucocorticoids in people at high risk for diabetes.
Status Unknown status The sponsor has not confirmed the status recently.
Phase Phase 3 Confirms effectiveness in a large group before approval.
Type Interventional (clinical trial)
Design Randomized, double-blind prevention study
Participants 36 people Planned (estimated).
Who can join Ages 18+ · all sexes
Timeline Started 2014-01
Where 1 site · Israel
What this study is testing ClinicalTrials.gov NCT02016846 ↗
Description as written by the study sponsor.
Glucocorticoids therapy exposes the patient to an increased risk for diabetes morbidity. However, there is no proven preventive therapy. GLP-1-RA has shown to improve glucose metabolism in healthy volunteers treated with glucocorticoids. We assume that GLP-1-RA will improve glucose metabolism in patients with high risk for diabetes morbidity, treated with glucocorticoids.
Treatments tested
- Liraglutide Drug
- Placebo Drug
| Main thing measured | Glucose levels 2 hours after 75 gr OGTT |
|---|---|
| Sponsor | Rabin Medical Center |
| Conditions studied | Glucocorticoid Induced Hyperglycemia |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02016846 ↗